GSK Hits Back At Solicitor General On US Skinny Labels
Originator’s Brief Urges Supreme Court Not To Grant Teva Request To Review Case
GSK has filed a supplemental brief pushing back against a recent opinion from the US solicitor general that suggested the country’s Supreme Court should re-examine long-running litigation with Teva over skinny-label generics with carved-out indications.
